The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework

Siegel, Geoffrey; Biermann, J. Sybil; Chugh, Rashmi; Jacobson, Jon A.; Lucas, David R.; Feng, Mary; Chang, Andrew C.; Smith, Sean R.; Wong, Sandra L.; Hasen, Jill M

doi:10.2147/jmdh.s49805

Cited by 30 publications

(13 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous publications have argued the necessity of having MDTs to achieve a successful outcome in sarcoma care [1-8]. Interesting evidence also derives from case/cohort studies, some of which involved > 1,000 patients (Table 1) [5, 9-14].…”

Section: Reference Centresmentioning

confidence: 99%

Advancing towards Better Cooperation for Better Sarcoma Prognoses

Broto

2018

Oncology

View full text Add to dashboard Cite

Multidisciplinary teams (MDTs) are necessary to deliver the best sarcoma care. Planning the optimal therapeutic strategy per patient requires input and expertise from several disciplines. Case/cohort studies have reported improved patient outcomes associated with treatment by MDTs and/or treatment in sarcoma centres. Many countries have established national networks of sarcoma reference centres and most have developed evidence-based clinical practice guidelines agreed using multidisciplinary expertise. In many countries, sarcoma networks are organised as cooperative groups. These groups are committed to delivering continuing medical education and are open to collaboration with other groups. Among their many benefits, cooperative groups have huge capacity for accrual, which is essential for rare cancers such as sarcoma. Since its beginnings in 1994 with a small core of oncologists focussing on soft tissue sarcoma, the Spanish Group for Research on Sarcomas (GEIS) has expanded to 376 members from more than 10 disciplines (as at June 2017). GEIS is currently actively collaborating with several international cooperative groups. As MDTs are essential to offer the best outcome in sarcoma care, and international cooperation between sarcoma groups is essential to address the many unanswered questions in sarcoma management, both approaches should be made mandatory.

show abstract

Section: Reference Centresmentioning

confidence: 99%

Advancing towards Better Cooperation for Better Sarcoma Prognoses

Broto

2018

Oncology

View full text Add to dashboard Cite

show abstract

“…The advantages of ultrasound-guided biopsy for the diagnosis of musculoskeletal tissue lesions are well-known ( 1 – 3 ) . A modern approach to diagnosis and the importance of the multidisciplinary tumor board in patient survival have been emphasized ( 4 – 6 ) . Diagnostic imaging with radiography, magnetic resonance imaging (MRI), computed tomography (CT), and ultrasonography is helpful in the process of differential diagnosis.…”

Section: Introductionmentioning

confidence: 99%

The diagnostic value of ultrasound-guided percutaneous core needle biopsy of musculoskeletal soft tissue lesions

et al. 2021

View full text Add to dashboard Cite

Introduction: Percutaneous ultrasound-guided core needle biopsy is a well-established method in the diagnosis of musculoskeletal tumors. It is unclear which factors contribute the most to a successful biopsy. The aim of the study was to determine the value of ultrasoundguided core needle biopsy of solid lesions in the musculoskeletal system using a 16-gauge needle. Material and methods: A retrospective analysis performed at a regional sarcoma center over one year included patients referred for ultrasound-guided biopsy of musculoskeletal soft tissue lesions. At least 6 months’ clinical and radiological follow-up, results from repeat or excisional biopsy, or interventional treatment, served as outcome reference. The biopsy procedure and yield were analyzed. The biopsy was classified as ‘diagnostic’ when a definitive diagnosis could be made on the first biopsy, and ‘accurate’ when only the malignant or benign nature of the tumor could be determined. Results: From 102 referrals for biopsy of soft tissue lesions in 2019, a total of 73 biopsies of solid lesions with a 16-gauge cutting needle were included (73 patients). There were 34 males and 39 females, with a mean age of 57.7 years. The overall proportion of diagnostic biopsies was 84%, for malignant lesions 88% and benign lesions 81%. The tumor could be classified as malignant or benign in 12 patients (16%) (accurate biopsy). It was possible to discriminate between malignant and benign lesions in each case. The majority of biopsied lesions were benign 64% (n = 47). Conclusion: The diagnostic value of ultrasound-guided percutaneous core needle biopsy of musculoskeletal soft tissue lesions performed with 16-gauge needle is good, with a high rate of diagnostic biopsies, both for benign and malignant lesions.

show abstract

“…Central to cancer management in the modern era is the role of a multi-disciplinary team (MDT) meeting, which optimizes coordination between healthcare professionals in their management decisions of patients. Enabling better coordination and communication, MDTs have facilitated improved decisionmaking amongst specialists bene tting patient care immensely [1][2][3] . As the standard of care in most countries, MDTs have positively in uenced patient assessment and management practices in cancer care especially with modi cation of diagnosis, thereby ensuring the appropriate treatment plan is undertaken [4][5][6] .…”

Section: Introductionmentioning

confidence: 99%

Will Virtual Multidisciplinary Team Meetings Become the Norm for Musculoskeletal Oncology Care following the COVID-19 Pandemic? - Experience from a tertiary sarcoma centre

Rajasekaran

Whitwell

Cosker

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Like with all cancers, multidisciplinary team (MDT) meetings are the norm in bone and soft tissue tumour (BST) management too. Problem in attendance of specialists due to geographical location is the one of the key barriers to effective functioning of MDTs. To overcome this problem, virtual MDTs involving videoconferencing or telemedicine have been proposed, but however this has been seldom used and tested. The COVID-19 pandemic forced the implementation of virtual MDTs in the Oxford sarcoma service in order to maintain normal service provision. We conducted a survey among the participants to evaluate its efficacy.Methods: An online questionnaire comprising of 24 questions organised into 4 sections was circulated among all participants of the MDT after completion of 8 virtual MDTs. Opinions were sought comparing virtual MDTs to the conventional face-to-face MDTs on various aspects. A total of 36 responses were received and were evaluated.Results: 72.8% were satisfied with the depth of discussion in virtual MDTs and 83.3% felt that the decision-making in diagnosis had not changed following the switch from face-to-face MDTs. About 86% reported to have all essential patient data was available to make decisions and 88.9% were satisfied with the time for discussion of patient issues over virtual platform. Three-fourths of the participants were satisfied (36.1% - highly satisfied; 38.9% - moderately satisfied) with virtual MDTs and 55.6% of them were happy to attend MDTs only by the virtual platform in the future. Regarding future, 77.8% of the participants opined that virtual MDTs would be the future of cancer care and an overwhelming majority (91.7%) felt that the present exercise would serve as a precursor to global MDTs involving specialists from abroad in the future.Conclusion: Our study shows that the forced switch to virtual MDTs in sarcoma care following the unprecedented COVID-19 pandemic to be a viable and effective alternative to conventional face-to-face MDTs. With effective and efficient software in place, virtual MDTs would also facilitate in forming extended MDTs in seeking opinions on complex cases from specialists abroad and can expand cancer care globally.

show abstract

The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework

Cited by 30 publications

References 12 publications

Advancing towards Better Cooperation for Better Sarcoma Prognoses

Advancing towards Better Cooperation for Better Sarcoma Prognoses

The diagnostic value of ultrasound-guided percutaneous core needle biopsy of musculoskeletal soft tissue lesions

Will Virtual Multidisciplinary Team Meetings Become the Norm for Musculoskeletal Oncology Care following the COVID-19 Pandemic? - Experience from a tertiary sarcoma centre

Contact Info

Product

Resources

About